Formyl peptide receptor-like 2 is expressed and functional in plasmacytoid dendritic cells, tissue-specific macrophage subpopulations, and eosinophils.
Devosse. Thalie T; Guillabert. Aude A; D'Haene. Nicky N; Berton. Alix A; De Nadai. Patricia P; Noel. Sophie S; Brait. Maryse M; Franssen. Jean-Denis JD; Sozzani. Silvano S; Salmon. Isabelle I; Parmentier. Marc M
Key Findings
- FPRL2 is highly expressed and functional in plasmacytoid dendritic cells and increases when they mature
- Eosinophils express FPRL2 and move toward humanin/F2L but don’t release granules
- Specific macrophage subsets in lung, colon, and skin express FPRL2, linking it to barrier immunity
Practical Outcomes
- Humanin might influence immune cell migration and activity via FPRL2, hinting at potential immune‑modulating effects. However, the research is basic and does not provide actionable dosing or supplementation guidance for longevity or performance, so biohackers should wait for more applied studies before incorporating it into protocols.
Summary
The study shows that the humanin peptide can bind to a specific immune receptor (FPRL2) found on certain immune cells like plasmacytoid dendritic cells, eosinophils, and some tissue‑specific macrophages, especially in the lung, colon, and skin. This suggests humanin may play a role in regulating innate immunity, but the paper doesn’t give any dosage or protocol advice for health‑hacking purposes.
Abstract
The formyl peptide receptor (FPR) is a key player in innate immunity and host defense mechanisms. In humans and other primates, a cluster of genes encodes two related receptors, FPR-like 1 and FPR-like 2 (FPRL1 and FPRL2). Despite their high sequence similarity, the three receptors respond to different sets of ligands and display a different expression pattern in leukocyte populations. Unlike FPR and FPRL1, FPRL2 is absent from neutrophils, and two endogenous peptide agonists, F2L and humanin, were recently described. In the present work, we investigated the detailed functional distribution of FPRL2 in leukocytes by quantitative PCR, flow cytometry, immunohistochemistry, and chemotaxis assays, with the aim of raising hypotheses regarding its potential functions in the human body. We describe that FPRL2 is highly expressed and functional in plasmacytoid dendritic cells and up-regulated upon their maturation. FPRL2 is also expressed in eosinophils, which are recruited but do not degranulate in response to F2L. FPRL2 is expressed and functional in macrophages differentiated from monocytes in vitro in different conditions. However, in vivo, only specific subsets of macrophages express the receptor, particularly in the lung, colon, and skin, three organs chronically exposed to pathogens and exogenous aggressions. This distribution and the demonstration of the production of the F2L peptide in mice underline the potential role of FPRL2 in innate immunity and possibly in immune regulation and allergic diseases.
Study Information
pubmed
2009
2009-04-15T00:00:00.000Z
10.4049/jimmunol.0803128
79
63